CYT-0851: Clinical Trials

1 trial of CYT-0851, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow CYT-0851: new trials by email Literature Review of CYT-0851 trials Research Report on CYT-0851

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
CYT-0851, CYT-0851 in combination with gemcitabine, CYT-0851 in combination with capecitabine - Malignancy, Non-hodgkin Lymphoma
Phase 1 / Phase 2CompletedCyteir Therapeutics, Inc.1692019-10-092024-12-24

Conditions studied

Breast Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Multiple Myeloma (1)  ·  Neoplasms (1)  ·  Ovarian Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Sarcoma (1)  ·  Small Cell Lung Carcinoma (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Triple Negative Breast Neoplasms (1)

Sponsors

Cyteir Therapeutics, Inc. (1)

Countries

United States (1)

Top investigators

Markus Renschler, MD (1)